Hidetoshi Nomoto

845 total citations
31 papers, 214 citations indexed

About

Hidetoshi Nomoto is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Hidetoshi Nomoto has authored 31 papers receiving a total of 214 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 8 papers in Epidemiology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Hidetoshi Nomoto's work include SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (8 papers) and SARS-CoV-2 detection and testing (5 papers). Hidetoshi Nomoto is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (8 papers) and SARS-CoV-2 detection and testing (5 papers). Hidetoshi Nomoto collaborates with scholars based in Japan, United States and Australia. Hidetoshi Nomoto's co-authors include Norio Ohmagari, Satoshi Kutsuna, Tetsuya Suzuki, Mugen Ujiie, Takaji Wakita, Makoto Kuroda, Tsuguto Fujimoto, Kayoko Hayakawa, Keiji Nakamura and Kei Yamamoto and has published in prestigious journals such as PLoS ONE, Emerging infectious diseases and Journal of Medical Microbiology.

In The Last Decade

Hidetoshi Nomoto

22 papers receiving 211 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hidetoshi Nomoto Japan	8	157	38	33	21	18	31	214
Alyssia Robinson Canada	7	211 1.3×	35 0.9×	51 1.5×	11 0.5×	7 0.4×	15	260
Zhaofang Jiang China	6	247 1.6×	58 1.5×	43 1.3×	41 2.0×	40 2.2×	9	340
Reynolds M. Salerno United States	8	112 0.7×	88 2.3×	29 0.9×	18 0.9×	5 0.3×	29	242
Reed Magleby United States	7	308 2.0×	43 1.1×	84 2.5×	22 1.0×	58 3.2×	13	378
Kerri Basile Australia	13	287 1.8×	56 1.5×	96 2.9×	56 2.7×	10 0.6×	19	391
Elio Issa Lebanon	7	180 1.1×	63 1.7×	39 1.2×	7 0.3×	25 1.4×	9	283
Jianning Tong China	6	258 1.6×	24 0.6×	37 1.1×	17 0.8×	50 2.8×	7	329
J.L. Schmit France	8	154 1.0×	13 0.3×	21 0.6×	15 0.7×	18 1.0×	14	200
Tomasz Smiatacz Poland	8	82 0.5×	15 0.4×	68 2.1×	9 0.4×	30 1.7×	23	210
Marthe Charles Canada	9	158 1.0×	60 1.6×	77 2.3×	67 3.2×	5 0.3×	38	275

Countries citing papers authored by Hidetoshi Nomoto

Since Specialization

Citations

This map shows the geographic impact of Hidetoshi Nomoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidetoshi Nomoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidetoshi Nomoto more than expected).

Fields of papers citing papers by Hidetoshi Nomoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidetoshi Nomoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidetoshi Nomoto. The network helps show where Hidetoshi Nomoto may publish in the future.

Co-authorship network of co-authors of Hidetoshi Nomoto

This figure shows the co-authorship network connecting the top 25 collaborators of Hidetoshi Nomoto. A scholar is included among the top collaborators of Hidetoshi Nomoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidetoshi Nomoto. Hidetoshi Nomoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Iwamoto, Noriko, et al.. (2024). Characteristics of Streptococcal Toxic Shock Syndrome Caused by Different Beta-hemolytic Streptococci Species: A Single-center Retrospective Study. Open Forum Infectious Diseases. 11(9). ofae486–ofae486. 2 indexed citations

Nomoto, Hidetoshi, Noriko Iwamoto, Kei Yamamoto, et al.. (2024). Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymphoma. Journal of Infection and Chemotherapy. 30(8). 793–795. 5 indexed citations

Nakamoto, Takato, Noriko Iwamoto, Keiji Nakamura, et al.. (2024). COVID-19 severity and corticosteroid treatment have minimal effect on specific antibody production. BMC Infectious Diseases. 24(1). 1197–1197.

Salmon, Sharon, et al.. (2024). Global Outbreak Alert and Response Network (GOARN) focal point engagement meeting with partners in Japan. Western Pacific surveillance response journal. 15(5). 19–21.

Suzuki, Tetsuya, Yusuke Asai, Shinya Tsuzuki, et al.. (2023). Real-world effectiveness of full and booster mRNA vaccination for coronavirus disease 2019 against disease severity during the delta- and omicron-dominant phases: A propensity score-matched cohort study using the nationwide registry data in Japan. Journal of Microbiology Immunology and Infection. 57(1). 20–29.

Nomoto, Hidetoshi, Kei Yamamoto, Satoshi Kutsuna, et al.. (2023). Evaluation of potential rabies exposure among Japanese international travelers: A retrospective descriptive study. PLoS ONE. 18(8). e0287838–e0287838.

Kawashima, Akira, Hidetoshi Nomoto, Hidekazu Takagi, et al.. (2023). Mansonella perstans infection in a Gabonese immigrant in Japan: an illustrative case of a clinical conundrum and management dilemma. Journal of Travel Medicine. 30(7). 1 indexed citations

Hayakawa, Kayoko, Kei Yamamoto, Hidetoshi Nomoto, et al.. (2023). Imported severe Plasmodium falciparum infection in the first trimester of pregnancy complicated by post-artemisinin delayed hemolysis and intrauterine fetal death, a case report. Tropical Medicine and Health. 51(1). 25–25.

Nakamura, Keiji, Kayoko Hayakawa, Shinya Tsuzuki, et al.. (2023). Clinical outcomes and epidemiological characteristics of bacteremia in the older Japanese population. Journal of Infection and Chemotherapy. 29(10). 971–977. 3 indexed citations

10.

Asai, Yusuke, Hidetoshi Nomoto, Kayoko Hayakawa, et al.. (2022). Comorbidities as Risk Factors for Severe Disease in Hospitalized Elderly COVID-19 Patients by Different Age-Groups in Japan. Gerontology. 68(9). 1027–1037. 24 indexed citations

11.

Nomoto, Hidetoshi, Yusuke Asai, Kayoko Hayakawa, et al.. (2022). Impact of the COVID-19 pandemic on racial and ethnic minorities in Japan. Epidemiology and Infection. 150. e202–e202. 2 indexed citations

12.

Nomoto, Hidetoshi, Satoshi Kutsuna, Kazu Okuma, et al.. (2021). No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity. Journal of Infection and Chemotherapy. 27(4). 653–655. 2 indexed citations

13.

Nomoto, Hidetoshi, Masahiro Ishikane, Takahiro Maeki, et al.. (2021). Facilitating the deployment of Japanese human resources for responding global outbreaks of emerging and Re-emerging infectious diseases: A cross-sectional study. Journal of Infection and Chemotherapy. 28(1). 41–46. 3 indexed citations

14.

Nomoto, Hidetoshi, Satoshi Kutsuna, Mugen Ujiie, et al.. (2021). Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan. Emerging infectious diseases. 27(4). 95 indexed citations

15.

Nomoto, Hidetoshi, Kei Yamamoto, Gen Yamada, et al.. (2021). Time-course evaluation of the quantitative antigen test for severe acute respiratory syndrome coronavirus 2: The potential contribution to alleviating isolation of COVID-19 patients. Journal of Infection and Chemotherapy. 27(11). 1669–1673. 7 indexed citations

16.

Yamamoto, Kei, Michiyo Suzuki, Gen Yamada, et al.. (2021). Utility of the antigen test for coronavirus disease 2019: Factors influencing the prediction of the possibility of disease transmission. International Journal of Infectious Diseases. 104. 65–72. 12 indexed citations

17.

Nakamura, Keiji, Hidetoshi Nomoto, Sohei Harada, et al.. (2021). Infection with capsular genotype K1-ST23 hypervirulent Klebsiella pneumoniae isolates in Japan after a stay in East Asia: Two cases and a literature review. Journal of Infection and Chemotherapy. 27(10). 1508–1512. 11 indexed citations

18.

Yamamoto, Kei, Kazuhisa Mezaki, MASAMI KUROKAWA, et al.. (2021). Negative Results of Nucleic Acid Amplification Tests for SARS-CoV-2 in Clinical Practice May Vary among Six Molecular Assays in Patients with COVID-19. Japanese Journal of Infectious Diseases. 75(3). 309–313. 1 indexed citations

19.

Nomoto, Hidetoshi, Masahiro Ishikane, Takato Nakamoto, et al.. (2020). Conjunctivitis, the key clinical characteristic of adult rubella in Japan during two large outbreaks, 2012–2013 and 2018–2019. PLoS ONE. 15(4). e0231966–e0231966. 8 indexed citations

20.

Nomoto, Hidetoshi, Satoshi Kutsuna, Keiji Nakamura, et al.. (2020). Totally implantable venous access port infection caused by Staphylococcus pseudintermedius: Possible transmission from a companion dog to a human. Journal of Infection and Chemotherapy. 26(12). 1305–1308. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact